Method of treatment of diabetes and/or obesity with reduced nausea side effect
US8039432B2 · kind B2 · utility
38Cited by
85References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 9, 2006 |
| Grant date | Oct 18, 2011 |
| Priority date | — |
| Expiry date | Feb 26, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods of administering an insulinotropic peptide in an amount effective to treat a disorder or condition while reducing nausea side effect by administering to a subject in need thereof an insulinotropic peptide conjugated to albumin. The present invention also provides methods of selecting a subject for administration of a conjugated insulinotropic peptide. Exemplary disorders or conditions treatable with an insulinotropic peptide include obesity and type II diabetes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.